Localized Optogenetic Targeting of Rotors in Atrial Cardiomyocyte Monolayers
暂无分享,去创建一个
Alexander V Panfilov | Martin J Schalij | Rupamanjari Majumder | A. Panfilov | M. Schalij | I. Feola | A. Teplenin | A. D. de Vries | D. Pijnappels | R. Majumder | Linda Volkers | Antoine A F de Vries | Daniël A Pijnappels | Iolanda Feola | Alexander Teplenin | L. Volkers
[1] J. Bates,et al. Prospective, Tissue-Specific Optimization of Ablation for Multiwavelet Reentry: Predicting the Required Amount, Location, and Configuration of Lesions , 2016, Circulation. Arrhythmia and electrophysiology.
[2] D. Ypey,et al. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes. , 2014, Cardiovascular research.
[3] Aristides B. Arrenberg,et al. Optogenetic Control of Cardiac Function , 2010, Science.
[4] José Jalife,et al. Rotors and the Dynamics of Cardiac Fibrillation , 2013, Circulation research.
[5] J. Bates,et al. Ablation of multi-wavelet re-entry: general principles and in silico analyses. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] Francesco S. Pavone,et al. Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation , 2016, Scientific Reports.
[7] I. Feola,et al. Optogenetic Engineering of Atrial Cardiomyocytes. , 2016, Methods in molecular biology.
[8] V. Santinelli,et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.
[9] L. Gepstein,et al. Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins. , 2014, Cardiovascular research.
[10] Alexander V Panfilov,et al. Small size ionic heterogeneities in the human heart can attract rotors. , 2014, American journal of physiology. Heart and circulatory physiology.
[11] Udi Nussinovitch,et al. Optogenetics for in vivo cardiac pacing and resynchronization therapies , 2015, Nature Biotechnology.
[12] Andrés Orozco-Duque,et al. Effect of the electrograms density in detecting and ablating the tip of the rotor during chronic atrial fibrillation: an in silico study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] D. Atsma,et al. Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. , 2011, Cardiovascular research.
[14] D. Levy,et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.
[15] Frank Bogun,et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.
[16] M. Schalij,et al. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management , 2016, European heart journal.
[17] D. Ypey,et al. Optogenetic manipulation of anatomical re-entry by light-guided generation of a reversible local conduction block , 2017, Cardiovascular research.
[18] Hugh Calkins,et al. Catheter ablation in patients with persistent atrial fibrillation , 2016, European heart journal.
[19] O. Alfieri,et al. Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation: Efficacy of an Anatomic Approach in a Large Cohort of Patients With Atrial Fibrillation , 2001, Circulation.
[20] D. Haines,et al. Cellular Electrophysiological Effects of Hyperthermia on Isolated Guinea Pig Papillary Muscle Implications for Catheter Ablation , 1993, Circulation.
[21] Wouter-Jan Rappel,et al. Mechanisms for the Termination of Atrial Fibrillation by Localized Ablation: Computational and Clinical Studies , 2015, Circulation. Arrhythmia and electrophysiology.
[22] Thomas V. Karathanos,et al. Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations. , 2016, The Journal of clinical investigation.
[23] Wouter-Jan Rappel,et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.
[24] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[25] Lluís Mont,et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) , 2013, European heart journal.
[26] Roland N. Emokpae,et al. Spiral Wave Attachment to Millimeter-Sized Obstacles , 2006, Circulation.
[27] C. Murray,et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.
[28] T. Bruegmann,et al. Optogenetic control of heart muscle in vitro and in vivo , 2010, Nature Methods.